$RPTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Repare Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Repare Therapeutics Inc.. Get notifications about new insider transactions in Repare Therapeutics Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 4,328 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 4,328 | 0 | 4,328 | 0 to 4.3 K |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 20,037 | 0 | 160,958 | 181 K to 161 K (-11.07 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 60,472 | 0 | 0 | 60.5 K to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 1,893 | 0 | 60,472 | 58.6 K to 60.5 K (+3.23 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 8,766 | 0 | 70,422 | 79.2 K to 70.4 K (-11.07 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 1,711 | 0 | 58,579 | 56.9 K to 58.6 K (+3.01 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 7,919 | 0 | 63,619 | 71.5 K to 63.6 K (-11.07 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 56,868 | 0 | 56,868 | 0 to 56.9 K |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 263,278 | 0 | 2,114,947 | 2.4 M to 2.1 M (-11.07 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 6 | 0 | 8,076 | 8.1 K to 8.1 K (+0.07 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 50,000 | 0 | 508,282 | 558.3 K to 508.3 K (-8.96 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 4,313 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 4,313 | 0 | 4,313 | 0 to 4.3 K |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 687 | 0 | 8,070 | 7.4 K to 8.1 K (+9.31 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 250,000 | 0 | 2,894,451 | 3.1 M to 2.9 M (-7.95 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 2,764 | 0 | 7,383 | 4.6 K to 7.4 K (+59.84 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 4,328 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 4,328 | 0 | 4,328 | 0 to 4.3 K |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 20,037 | 0 | 160,958 | 181 K to 161 K (-11.07 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,820 | 0 | 4,619 | 2.8 K to 4.6 K (+65.02 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 60,472 | 0 | 0 | 60.5 K to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,893 | 0 | 60,472 | 58.6 K to 60.5 K (+3.23 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 8,766 | 0 | 70,422 | 79.2 K to 70.4 K (-11.07 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,711 | 0 | 58,579 | 56.9 K to 58.6 K (+3.01 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 7,919 | 0 | 63,619 | 71.5 K to 63.6 K (-11.07 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 56,868 | 0 | 56,868 | 0 to 56.9 K |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 263,278 | 0 | 2,114,947 | 2.4 M to 2.1 M (-11.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 50,000 | 0 | 558,282 | 608.3 K to 558.3 K (-8.22 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 4,744 | 0 | 0 | 4.7 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 4,744 | 0 | 4,744 | 0 to 4.7 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 5,500 | 0 | 0 | 5.5 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 5,500 | 0 | 5,500 | 0 to 5.5 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 275,000 | 0 | 3,144,451 | 3.4 M to 3.1 M (-8.04 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 1,388 | 0 | 0 | 1.4 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 1,388 | 0 | 1,388 | 0 to 1.4 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 11,688 | 0 | 180,995 | 192.7 K to 181 K (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 35,276 | 0 | 0 | 35.3 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 1,105 | 0 | 35,276 | 34.2 K to 35.3 K (+3.23 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 5,113 | 0 | 79,188 | 84.3 K to 79.2 K (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 998 | 0 | 34,171 | 33.2 K to 34.2 K (+3.01 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 4,620 | 0 | 71,538 | 76.2 K to 71.5 K (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 33,173 | 0 | 33,173 | 0 to 33.2 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 153,579 | 0 | 2,378,225 | 2.5 M to 2.4 M (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 50,000 | 0 | 558,282 | 608.3 K to 558.3 K (-8.22 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 4,744 | 0 | 0 | 4.7 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 4,744 | 0 | 4,744 | 0 to 4.7 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 5,500 | 0 | 0 | 5.5 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 5,500 | 0 | 5,500 | 0 to 5.5 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 275,000 | 0 | 3,144,451 | 3.4 M to 3.1 M (-8.04 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 1,388 | 0 | 0 | 1.4 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 1,388 | 0 | 1,388 | 0 to 1.4 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 11,688 | 0 | 180,995 | 192.7 K to 181 K (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 35,276 | 0 | 0 | 35.3 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 1,105 | 0 | 35,276 | 34.2 K to 35.3 K (+3.23 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 5,113 | 0 | 79,188 | 84.3 K to 79.2 K (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 998 | 0 | 34,171 | 33.2 K to 34.2 K (+3.01 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 4,620 | 0 | 71,538 | 76.2 K to 71.5 K (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 33,173 | 0 | 33,173 | 0 to 33.2 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 153,579 | 0 | 2,378,225 | 2.5 M to 2.4 M (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 6 | 0 | 2,799 | 2.8 K to 2.8 K (+0.21 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 50,000 | 0 | 558,282 | 608.3 K to 558.3 K (-8.22 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 4,744 | 0 | 0 | 4.7 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 4,744 | 0 | 4,744 | 0 to 4.7 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 756 | 0 | 2,793 | 2 K to 2.8 K (+37.11 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 5,500 | 0 | 0 | 5.5 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 5,500 | 0 | 5,500 | 0 to 5.5 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 275,000 | 0 | 3,144,451 | 3.4 M to 3.1 M (-8.04 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 975 | 0 | 2,037 | 1.1 K to 2 K (+91.81 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 1,388 | 0 | 0 | 1.4 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,388 | 0 | 1,388 | 0 to 1.4 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 11,688 | 0 | 180,995 | 192.7 K to 181 K (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,062 | 0 | 1,062 | 0 to 1.1 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 35,276 | 0 | 0 | 35.3 K to 0 (-100.00 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,105 | 0 | 35,276 | 34.2 K to 35.3 K (+3.23 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 5,113 | 0 | 79,188 | 84.3 K to 79.2 K (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 998 | 0 | 34,171 | 33.2 K to 34.2 K (+3.01 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 4,620 | 0 | 71,538 | 76.2 K to 71.5 K (-6.07 %) |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 33,173 | 0 | 33,173 | 0 to 33.2 K |
Jan 19 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 153,579 | 0 | 2,378,225 | 2.5 M to 2.4 M (-6.07 %) |
Dec 30 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 2.06 | 48 | 99 | 54,850 | |
Dec 30 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 35.01 | 950 | 33,260 | 50,533 | 51.5 K to 50.5 K (-1.85 %) |
Dec 30 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 34.63 | 4,207 | 145,688 | 51,483 | 55.7 K to 51.5 K (-7.55 %) |
Dec 30 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 33.30 | 14,539 | 484,149 | 55,690 | 70.2 K to 55.7 K (-20.70 %) |
Dec 30 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 34.60 | 322 | 11,141 | 70,229 | 70.6 K to 70.2 K (-0.46 %) |
Dec 30 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 34.24 | 14,726 | 504,218 | 70,551 | 85.3 K to 70.6 K (-17.27 %) |
Dec 30 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 2.06 | 48 | 99 | 85,277 | 85.2 K to 85.3 K (+0.06 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 2.06 | 432 | 891 | 54,898 | |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 2.43 | 9,488 | 23,008 | 148,466 | |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 2.06 | 4,771 | 9,838 | 55,330 | |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 1.64 | 1,976 | 3,235 | 11,856 | |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 2.06 | 25,606 | 52,800 | 60,101 | |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 1.64 | 15,706 | 25,711 | 13,832 | |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 33.14 | 432 | 14,316 | 85,229 | 85.7 K to 85.2 K (-0.50 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 2.06 | 432 | 891 | 85,661 | 85.2 K to 85.7 K (+0.51 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 34.26 | 3,679 | 126,043 | 85,229 | 88.9 K to 85.2 K (-4.14 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 33.48 | 12,556 | 420,375 | 88,908 | 101.5 K to 88.9 K (-12.37 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 2.43 | 9,488 | 23,008 | 101,464 | 92 K to 101.5 K (+10.32 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 2.06 | 4,771 | 9,838 | 91,976 | 87.2 K to 92 K (+5.47 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 1.64 | 1,976 | 3,235 | 87,205 | 85.2 K to 87.2 K (+2.32 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 33.36 | 39,700 | 1,324,392 | 85,229 | 124.9 K to 85.2 K (-31.78 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 34.00 | 1,612 | 54,808 | 124,929 | 126.5 K to 124.9 K (-1.27 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 2.06 | 25,606 | 52,800 | 126,541 | 100.9 K to 126.5 K (+25.37 %) |
Dec 28 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 1.64 | 15,706 | 25,711 | 100,935 | 85.2 K to 100.9 K (+18.43 %) |
Dec 22 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 2.43 | 40,000 | 97,000 | 157,954 | |
Dec 22 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 33.08 | 40,000 | 1,323,200 | 85,229 | 125.2 K to 85.2 K (-31.94 %) |
Dec 22 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 2.43 | 40,000 | 97,000 | 125,229 | 85.2 K to 125.2 K (+46.93 %) |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 2.06 | 8,321 | 17,158 | 85,707 | |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 1.64 | 2,080 | 3,405 | 29,538 | |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | M | 1.64 | 6,876 | 11,256 | 4,122 | |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 35.10 | 200 | 7,020 | 85,229 | 85.4 K to 85.2 K (-0.23 %) |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 34.59 | 8,121 | 280,905 | 85,429 | 93.6 K to 85.4 K (-8.68 %) |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 2.06 | 8,321 | 17,158 | 93,550 | 85.2 K to 93.6 K (+9.76 %) |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 36.01 | 934 | 33,633 | 85,229 | 86.2 K to 85.2 K (-1.08 %) |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Sell | S | 35.17 | 8,022 | 282,134 | 86,163 | 94.2 K to 86.2 K (-8.52 %) |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 1.64 | 2,080 | 3,405 | 94,185 | 92.1 K to 94.2 K (+2.26 %) |
Dec 18 2020 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Buy | M | 1.64 | 6,876 | 11,256 | 92,105 | 85.2 K to 92.1 K (+8.07 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 21,707 | 0 | 192,683 | 214.4 K to 192.7 K (-10.13 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 9,497 | 0 | 84,301 | 93.8 K to 84.3 K (-10.12 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 8,579 | 0 | 76,158 | 84.7 K to 76.2 K (-10.12 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 285,217 | 0 | 2,531,804 | 2.8 M to 2.5 M (-10.12 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 21,707 | 0 | 192,683 | 214.4 K to 192.7 K (-10.13 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 9,497 | 0 | 84,301 | 93.8 K to 84.3 K (-10.12 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 8,579 | 0 | 76,158 | 84.7 K to 76.2 K (-10.12 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 285,217 | 0 | 2,531,804 | 2.8 M to 2.5 M (-10.12 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 21,707 | 0 | 192,683 | 214.4 K to 192.7 K (-10.13 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 9,497 | 0 | 84,301 | 93.8 K to 84.3 K (-10.12 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 8,579 | 0 | 76,158 | 84.7 K to 76.2 K (-10.12 %) |
Dec 17 2020 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 285,217 | 0 | 2,531,804 | 2.8 M to 2.5 M (-10.12 %) |
Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 458,282 | 0 | 0 | |
Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 875,568 | 0 | 0 | |
Jun 25 2020 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,350 | 0 | 0 |